Live Breaking News & Updates on டோடோஸ் மருத்துவ|Page 7
Stay updated with breaking news from டோடோஸ் மருத்துவ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Posted on 5153 Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that the US Food & Drug Administration granted the Company a new Certificate of Free Sale for a second dosing regimen for Tollovid™ as a dietary supplement. Under the new Certificate of Free Sale, the Company is authorized to market Tollovid with a dosing regimen of 60 pills over a five-day period, equivalent to 12 pills per day. Tollovid, a potent 3CL protease inhibitor botanical product, is a dietary supplement that helps to support and maintain healthy immune function. The 3CL protease is an important part of certain coronavirus’ reproductive mechanism, and inhibiting this protease may help to support and maintain healthy immune function in the face of circulating coronaviruses. The Company sees this dosing regimen for Tollovid as optimal for supporting healthy immune fu ....
Pfizer s Covid-preventing pill could be available by the end of the year if human trials in the US and Belgium are successful. There are currently no drugs other than vaccines that can stop people developing Covid-19 – but if one is discovered it could spell the end of lockdowns forever, one expert has said. Pfizer, the company that made one of the most-used jabs in Europe and North America, is already testing its experimental pill on people. The antiviral drug, named PF-07321332, could be given to stop the illness getting severe in people who have started showing signs of coronavirus infection. ....
Puerto Rico-based The Strategic Group PR, LLC Has Sold Breast Cancer Detection Firm Provista Diagnostics, Inc. prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test Todos Medical Ltd.April 22, 2021 GMT
Todos plans to commercialize Videssa in late 2021 to reduce unnecessary biopsies in the $7.19 billion mammogram naïve market and integrate it into its TBIA Platform
Provista Diagnostics’ testing lab in the Atlanta, Georgia area is currently performing COVID-19 testing, that will be automated to significantly increase processing capacity Todos expects to employ testing methodologies to expand Provista’s capabilities regarding COVID variant identification NEW YORK, NY, and REHOVAT, ISRAEL, April 22, 2021 (GLOBE NEWSWIRE) via NewMediaWire Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has acquired Provista Diagnostics, Inc. Provi ....
Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.